---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-108900"
form_type: "8-K"
ticker: "NEOG"
cik: "0000711377"
company_name: "NEOGEN CORP"
filed_at: "2025-08-14T23:59:59+00:00"
generated_at: "2026-05-17T13:44:59.422322+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Neogen announces board retirement of William Boehm, appointment of Avi Pelossof effective Oct 23/24

## Summary
- William T. Boehm to retire from Neogen's Board effective Oct 23, 2025; served since 2011, chairs Audit Committee, member of Compensation & Talent Management Committee.
- Avi Pelossof appointed to Board effective Oct 24, 2025 as Class II director; over 25 yrs in diagnostics market, most recently CEO of Immucor.
- Pelossof previously Global President, Infectious Disease at Alere Inc., building a $750M portfolio and launching FDA CLIA-waived point-of-care test (now Abbott's ID NOW).
- Pelossof will participate in Neogen's non-employee director compensation program as described in 2024 proxy.

## SEC filing metadata
- accession: 0000950170-25-108900
- form_type: 8-K
- ticker: NEOG
- cik: 0000711377
- company_name: NEOGEN CORP
- filed_at: 2025-08-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/711377/000095017025108900/0000950170-25-108900-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/711377/000095017025108900/neog-20250814.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-108900
- JSON: https://secwatch.observer/filing/0000950170-25-108900.json
- Plain text: https://secwatch.observer/filing/0000950170-25-108900.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.